1. Home
  2. LC vs IRON Comparison

LC vs IRON Comparison

Compare LC & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LendingClub Corporation

LC

LendingClub Corporation

N/A

Current Price

$14.61

Market Cap

2.0B

Sector

Finance

ML Signal

N/A

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

N/A

Current Price

$65.81

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LC
IRON
Founded
2006
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
LC
IRON
Price
$14.61
$65.81
Analyst Decision
Buy
Strong Buy
Analyst Count
6
12
Target Price
$22.67
$101.67
AVG Volume (30 Days)
1.8M
997.1K
Earning Date
04-27-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
157.78
N/A
EPS
1.16
N/A
Revenue
$314,702,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$15.91
$101.57
P/E Ratio
$12.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.90
$30.82
52 Week High
$21.67
$99.50

Technical Indicators

Market Signals
Indicator
LC
IRON
Relative Strength Index (RSI) 39.88 46.47
Support Level $12.25 $57.45
Resistance Level $17.41 $69.36
Average True Range (ATR) 0.85 3.10
MACD 0.02 0.37
Stochastic Oscillator 21.68 66.05

Price Performance

Historical Comparison
LC
IRON

About LC LendingClub Corporation

LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: